Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes

This study aims to look at the impact on patient outcomes arising from measures implemented during the COVID-19 pandemic. The information and knowledge from this study will be useful for the management and allocation of hospital resources and patients in tne event of a disease outbreak.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgery COVID-19 Coronaviridae Infections Coronavirus Infections Disease Attributes Emergencies Infections Lung Diseases Neoplasms Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

21 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Cancer Center Singapore, Singapore

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

This study involves the extraction of patient records from the enterprise dataware house. As such, we do not stipulate the age limits.
Patients who had the following surgeries during over the period of 1 Jan 2017 to 31 December 2020
From the identified surgical procedure type or the following cancer-related procedures:

Breast
Colon
Liver
Rectum
Selected non-cancer surgeries:

Abdominal Wall
Gallbladder
Patients from SGH and its related institute NCC
Only local Singapore Citizens

Exclusion criteria

No exclusion criteria

Treatment and study plan

Primary outcomes

Analysis of patients according to type of surgical procedures, medical condition and dates of surgical treatment retrospectively.

Time frame: 1 Jan - 31 Dec 2017, 1 Jan - 31 Dec 2018, 1 Jan - 31 Dec 2019, 1 Jan - 31 Dec 2020

These patients are classified according to the institution, type of surgical procedures, the medical condition and the dates of surgical treatment. The study will be compared across four time periods.
Comparing surgical indices for high volume cancer and non-cancer diagnoses

Time frame: 1 Jan 2020 - 31 Dec 2020
The study focus on surgical indices for selected high-volume cancer and non-cancer diagnoses over the period 1st January2020 to 31 December 2020 and compare them with similar indices across the same period of time in the preceding 3 years in particular, for the following surgical procedures:
- Surgeries for the following cancer diagnoses:
- breast cancer, [XIV- N60, no malignancy], [Malignant, IINeoplasms- C50], colorectal cancer, [C18, 19, 20],
- hepatocellular carcinoma, [C22]
- Selected non-cancer surgeries:
- Cholecystectomy
- Abdominal hernia repair

Sponsors and collaborators

Lead sponsor

National Cancer Centre, Singapore

Other

Collaborators

National Medical Research Council (NMRC), Singapore

Registry information

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Jul 14, 2021
Registry last updated: Jul 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed